We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Theravance Biopharma
TBPH
$877M
| $812K | ﹤0.01% |
55,643
-1,665
| -3% | -$21K |
|
|
ALX
2302
Alexander's
ALX
$1.41B
| $812K | ﹤0.01% |
3,464
-320
| -8% | -$75.2K |
|
2303
MetroCity Bankshares
MCBS
$1.03B
| $812K | ﹤0.01% |
29,322
+26
| +0.1% | +$755 |
|
2304
Savers
SVV
$1.88B
| $805K | ﹤0.01% |
60,768
+19,145
| +46% | +$220K |
|
2305
GCM Grosvenor
GCMG
$820M
| $805K | ﹤0.01% |
66,655
+1,964
| +3% | +$24.3K |
|
2306
United States Antimony
UAMY
$1.02B
| $801K | ﹤0.01% |
129,239
-1,409
| -1% | -$5.89K |
|
2307
FerroAtlántica
GSM
$839M
| $801K | ﹤0.01% |
176,034
-2,577
| -1% | -$11K |
|
2308
Keros Therapeutics
KROS
$221M
| $799K | ﹤0.01% |
50,478
-1,337
| -3% | -$19.8K |
|
2309
AB InBev
BUD
$165B
| $797K | ﹤0.01% |
13,362
-1,732
| -11% | -$109K |
|
2310
SandRidge Energy
SD
$503M
| $796K | ﹤0.01% |
70,530
-3,293
| -4% | -$36.4K |
|
|
EU
2311
enCore Energy
EU
$243M
| $795K | ﹤0.01% |
247,748
-2,731
| -1% | -$7.35K |
|
2312
Kodiak Sciences
KOD
$2.84B
| $793K | ﹤0.01% |
48,459
-475
| -1% | -$4.09K |
|
2313
KT
KT
$8.81B
| $791K | ﹤0.01% |
40,585
-9,980
| -20% | -$203K |
|
|
TERN
2314
DELISTED
Terns Pharmaceuticals
TERN
| $787K | ﹤0.01% |
104,837
-1,614
| -2% | -$10.3K |
|
2315
Grindr
GRND
$2.95B
| $786K | ﹤0.01% |
52,343
-2,663
| -5% | -$46.7K |
|
2316
Eton Pharmaceutcials
ETON
$1.22B
| $785K | ﹤0.01% |
36,124
-470
| -1% | -$7.8K |
|
2317
Southern Missouri Bancorp
SMBC
$850M
| $785K | ﹤0.01% |
14,933
-203
| -1% | -$11.3K |
|
|
HONE
2318
DELISTED
HarborOne Bancorp
HONE
| $785K | ﹤0.01% |
57,691
-1,437
| -2% | -$18K |
|
2319
Rio Tinto
RIO
$164B
| $781K | ﹤0.01% |
11,832
-4,564
| -28% | -$282K |
|
2320
South Plains Financial
SPFI
$841M
| $780K | ﹤0.01% |
20,186
-436
| -2% | -$17K |
|
|
OPTU
2321
Optimum Communications Inc
OPTU
$301M
| $779K | ﹤0.01% |
323,331
-5,356
| -2% | -$13.1K |
|
2322
ClearPoint Neuro
CLPT
$433M
| $779K | ﹤0.01% |
35,746
-1,903
| -5% | -$22.4K |
|
2323
Global Industrial
GIC
$1.49B
| $778K | ﹤0.01% |
21,207
+666
| +3% | +$22.3K |
|
2324
Seneca Foods Class A
SENEA
$1.21B
| $777K | ﹤0.01% |
7,202
-217
| -3% | -$23K |
|
|
GES
2325
DELISTED
Guess Inc
GES
| $776K | ﹤0.01% |
46,431
+5,256
| +13% | +$77.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.